<table class="infobox infobox-gene">
<tr><th class="infobox-header" colspan="2">ATRX</th></tr>
<tr><td class="label">Full Name</td><td>Alpha Thalassemia/Mental Retardation Syndrome X-Linked</td></tr>
<tr><td class="label">Chromosome</td><td>Xq21.1</td></tr>
<tr><td class="label">NCBI Gene ID</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/546" target="_blank">546</a></td></tr>
<tr><td class="label">Ensembl ID</td><td>ENSG00000085224</td></tr>
<tr><td class="label">OMIM ID</td><td>300032</td></tr>
<tr><td class="label">UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/P46100" target="_blank">P46100</a></td></tr>
<tr><td class="label">Associated Diseases</td><td>ATR-X Syndrome, [Alzheimer's Disease](/diseases/alzheimers-disease), Glioblastoma, Intellectual Disability</td></tr>
</table>
ATRX — Alpha Thalassemia/Mental Retardation Syndrome X-Linked
Overview
Mermaid diagram (expand to render)
ATRX encodes a large ATP-dependent chromatin remodeler of the SWI/SNF family that plays essential roles in maintaining heterochromatin integrity, telomere stability, and genomic imprinting in the brain. ATRX functions as a histone H3.3 chaperone in complex with [DAXX](/genes/daxx), depositing the histone variant H3.3 at telomeres, pericentromeric heterochromatin, and retrotransposon-containing regions. Loss-of-function mutations cause ATR-X syndrome, an X-linked intellectual disability disorder characterized by severe cognitive impairment, alpha thalassemia, dysmorphic features, and urogenital abnormalities["@gibbons1995"].
Beyond its Mendelian disease association, ATRX has emerged as a significant player in neurodegenerative disease biology. Its roles in DNA damage repair, heterochromatin maintenance, and retrotransposon silencing intersect with key pathological mechanisms in [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative conditions. ATRX is also one of the most frequently mutated genes in brain tumors, where its loss activates the alternative lengthening of telomeres (ALT) pathway["@clynes2014"].
Gene Structure and Expression
ATRX is located on chromosome Xq21.1 and spans approximately 300 kb, making it one of the largest genes in the human genome. The gene encodes a 2492-amino acid protein containing two key functional domains:
- ADD domain (ATRX-DNMT3-DNMT3L; residues 159-296): A reader domain that recognizes histone H3 tails carrying the combination of K9me3 (trimethylation) and unmodified K4 — the hallmark of constitutive heterochromatin
- SWI/SNF2 helicase/ATPase domain (residues 1745-2492): Provides ATP-dependent chromatin remodeling activity, enabling nucleosome sliding and histone exchange
ATRX is highly expressed throughout the developing and adult brain, with particularly strong expression in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cerebral-cortex), [thalamus](/brain-regions/thalamus), and [cerebellum](/brain-regions/cerebellum). During development, ATRX expression is highest in neural progenitor cells and newly born [neurons](/entities/neurons), consistent with its essential role in neurogenesis[@brub2005].
Function
Heterochromatin Maintenance
ATRX is critical for maintaining constitutive heterochromatin in neurons:
- H3.3 deposition: The ATRX-DAXX complex deposits histone variant H3.3 at pericentromeric heterochromatin and telomeres
- Repetitive element silencing: ATRX maintains silencing of retrotransposons (LINE-1, SINE, ERV elements) through heterochromatin maintenance
- Centromere integrity: ATRX deposits H3.3 at centromeric CENP-A gaps, maintaining centromere function
- Imprinting: ATRX maintains allele-specific gene expression at imprinted loci in the brain
Telomere Protection
ATRX plays a vital role in telomere homeostasis:
- G-quadruplex resolution: ATRX resolves G-quadruplex (G4) structures at telomeric TTAGGG repeats, preventing replication stress and DNA damage
- Telomere capping: ATRX-mediated H3.3 deposition maintains telomeric heterochromatin, preventing telomere dysfunction-induced foci (TIFs)
- ALT suppression: ATRX prevents activation of the alternative lengthening of telomeres pathway
DNA Damage Response
In neurons, ATRX participates in DNA repair:
- Stalled replication fork processing: ATRX resolves G4 structures at stalled replication forks
- Homologous recombination: ATRX facilitates loading of recombination intermediates at sites of double-strand breaks
- Neuronal genome stability: ATRX protects against DNA damage accumulation in long-lived neurons that lack replicative DNA repair mechanisms[@watson2013]
Retrotransposon Silencing
A critical and underappreciated function:
- LINE-1 suppression: ATRX maintains repressive heterochromatin at LINE-1 retrotransposon loci, preventing their mobilization
- Neuronal transposition: In the absence of ATRX, LINE-1 elements can become de-repressed, leading to somatic retrotransposition events in neurons
- Genomic instability: Retrotransposon de-repression contributes to DNA damage, insertional mutagenesis, and inflammation via [cGAS-STING](/mechanisms/cgas-sting-neurodegeneration) activation
Disease Associations
ATR-X Syndrome
Loss-of-function ATRX mutations cause ATR-X syndrome (OMIM #301040), featuring:
- Severe intellectual disability: IQ typically below 50, with absent or minimal speech
- Alpha thalassemia: Mild hemoglobin H disease from dysregulated alpha-globin expression
- Characteristic facies: Telecanthus, flat nasal bridge, tented upper lip
- Urogenital abnormalities: Cryptorchidism, hypospadias, ambiguous genitalia
- Seizures: Present in approximately 30% of affected males
- Neurodegeneration: Some patients show progressive neurological decline with cortical atrophy on MRI[@gibbons2000]
Over 100 pathogenic ATRX mutations have been identified, clustering in the ADD domain and the SWI/SNF2 ATPase domain. Genotype-phenotype correlations show that mutations destroying ATPase activity cause more severe cognitive impairment.
Alzheimer's Disease
ATRX has several connections to [Alzheimer's disease](/diseases/alzheimers-disease) pathobiology:
- Heterochromatin loss: AD neurons show progressive loss of heterochromatin, a process that ATRX normally prevents. Reduced ATRX function may accelerate this age-dependent heterochromatin erosion[@sun2018]
- Retrotransposon activation: LINE-1 and other retrotransposons are de-repressed in AD brains. ATRX deficiency contributes to this de-repression, potentially triggering neuroinflammation via cytosolic DNA sensing
- [Tau](/genes/mapt)-chromatin interactions: Pathological [tau](/proteins/tau) has been shown to interact with heterochromatin and displace heterochromatin proteins. ATRX loss may synergize with tau pathology to exacerbate heterochromatin relaxation
- DNA damage accumulation: AD neurons show extensive DNA damage. ATRX dysfunction impairs DNA repair, potentially accelerating neurodegeneration
- Telomere shortening: Accelerated telomere shortening in AD correlates with disease progression. ATRX's role in telomere maintenance suggests its dysfunction could contribute to telomere-related neuronal aging[@guo2018]
Brain Tumors
ATRX is one of the most commonly mutated genes in diffuse gliomas:
- Astrocytoma: ATRX loss co-occurs with [IDH1/2](/genes/idh1) mutations and [TP53](/genes/tp53) mutations, defining the molecular subgroup of diffuse astrocytoma
- ALT activation: ATRX-null glioma cells activate ALT, providing telomere maintenance without telomerase
- Prognostic marker: ATRX status is a key diagnostic and prognostic marker in WHO CNS tumor classification[@cancer2015]
Aging and Neurodegeneration
Age-dependent ATRX dysfunction may contribute broadly to neurodegeneration:
- Epigenetic drift: ATRX protein levels decline with age in some neuronal populations, potentially contributing to age-dependent heterochromatin relaxation
- Satellite repeat instability: ATRX loss leads to pericentromeric satellite DNA instability, which can trigger [p53](/entities/tp53)-dependent senescence pathways
- Inflammatory signaling: Retrotransposon de-repression following ATRX decline activates [cGAS-STING](/mechanisms/cgas-sting-neurodegeneration), contributing to age-related neuroinflammation[@de2019]
Therapeutic Implications
Potential Interventions
- Retrotransposon inhibition: Reverse transcriptase inhibitors (e.g., lamivudine, stavudine) may suppress LINE-1 mobilization caused by ATRX dysfunction
- Heterochromatin restoration: [HDAC](/genes/hdac6) inhibitors or H3K9 methyltransferase activators to compensate for ATRX-dependent heterochromatin loss
- G-quadruplex stabilizers: Paradoxically, in some contexts, G4 ligands may modulate ATRX-associated pathology
- Gene therapy: ATRX gene replacement therapy for ATR-X syndrome, limited by the gene's enormous size (>7 kb cDNA)
Biomarker Potential
- ATRX immunohistochemistry is already used diagnostically in neuro-oncology
- Circulating retrotransposon transcripts as indirect markers of ATRX function
- Peripheral blood heterochromatin assays as aging biomarkers
Key Research Findings
- Gibbons et al. (1995) identified ATRX mutations as the cause of ATR-X syndrome[@gibbons1995]
- Goldberg et al. (2010) established ATRX as an H3.3 chaperone at telomeres and pericentromeric heterochromatin[@goldberg2010]
- Clynes et al. (2015) defined ATRX's role in suppressing ALT and maintaining telomere integrity[@clynes2014]
- Sun et al. (2018) linked heterochromatin disruption to tau pathology in Alzheimer's disease[@sun2018]
- De Cecco et al. (2019) demonstrated retrotransposon activation in aging and neurodegeneration[@de2019]
See Also
- [DAXX](/genes/daxx) — ATRX partner in H3.3 deposition
- [MECP2](/genes/mecp2) — Another X-linked chromatin regulator causing intellectual disability
- [DNMT3A](/genes/dnmt3a) — DNA methyltransferase with structural homology to ATRX ADD domain
- [TP53](/genes/tp53) — Co-mutated with ATRX in gliomas
- [Epigenetic Dysregulation in Neurodegeneration](/mechanisms/epigenetic-dysregulation-neurodegeneration)
- [Heterochromatin Loss in Aging](/mechanisms/heterochromatin-loss-aging)
External Links
- [NCBI Gene: ATRX](https://www.ncbi.nlm.nih.gov/gene/546)
- [UniProt: P46100](https://www.uniprot.org/uniprot/P46100)
- [GeneCards: ATRX](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ATRX)
- [OMIM: 300032](https://omim.org/entry/300032)
- [Allen Brain Atlas: ATRX](https://portal.brain-map.org/explore/genes?searchType=gene&query=ATRX)
References
[Gibbons RJ et al, Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome) (1995)](https://pubmed.ncbi.nlm.nih.gov/7789175/)
[Clynes D et al, ATRX dysfunction induces replication defects in primary mouse cells (2014)](https://pubmed.ncbi.nlm.nih.gov/24523394/)
[Bérubé NG et al, The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis (2005)](https://pubmed.ncbi.nlm.nih.gov/16239144/)
[Watson LA et al, Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span (2013)](https://pubmed.ncbi.nlm.nih.gov/23707062/)
[Gibbons RJ, Higgs DR, Molecular-clinical spectrum of the ATR-X syndrome (2000)](https://pubmed.ncbi.nlm.nih.gov/10942092/)
[Sun W et al, Loss of heterochromatin and retrotransposon activation in tau-driven neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29432131/)
[Guo C et al, Tau activates transposable elements in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30559440/)
[Cancer Genome Atlas Research Network, Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas (2015)](https://pubmed.ncbi.nlm.nih.gov/26061751/)
[De Cecco M et al, L1 drives IFN in senescent cells and promotes age-associated inflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/30485811/)
[Goldberg AD et al, Distinct factors control histone variant H3.3 localization at specific genomic regions (2010)](https://pubmed.ncbi.nlm.nih.gov/21076509/)Pathway Diagram
The following diagram shows the key molecular relationships involving ATRX — Alpha Thalassemia/Mental Retardation Syndrome X-Linked discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)